SAN DIEGO, Dec. 15, 2011 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that the company has been upgraded to the NASDAQ Global Select Market, a segment of the NASDAQ Global Market with the highest initial listing standards of any exchange in the world.
Sequenom will continue to trade under the ticker symbol, "SQNM," and will transfer its stock listing starting on January 3, 2012.
"As Sequenom continues to advance its mission of improving healthcare through revolutionary genetic analysis, we appreciate the opportunity to be recognized among the most innovative companies in the world on the NASDAQ Global Select Market," said Harry F. Hixson, Jr., Ph.D., Chairman and CEO, Sequenom.
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.
SEQUENOM ® is a trademark of Sequenom, Inc. All other trademarks and service marks are the property of their respective owners. <
|SOURCE Sequenom, Inc.|
Copyright©2010 PR Newswire.
All rights reserved